Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Laval

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neuromuscular Disorders : NMD|March 12, 2013
Muscular dystrophy in dysferlin-deficient mouse modelsMark A Hornsey, Steven H Laval, Rita Barresi, et al.
Human Molecular Genetics|February 12, 2010
Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromesJuliane S Müller, Catherine D Jepson, Steven H Laval, et al.
Nucleic Acid Therapeutics|July 16, 2015
Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino OligonucleotidesUmar Burki, Jonathan Keane, Alison Blain, et al.
Journal of Cardiovascular Translational Research|April 22, 2015
Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx MiceAlison Blain, Elizabeth Greally, Steven H Laval, et al.
Neuromuscular Disorders : NMD|December 3, 2014
Assessment of ventricular function in mouse models of muscular dystrophy: a comparison of MRI with conductance catheterAlison M Blain, Elizabeth Greally, Steven H Laval, et al.
The Journal of Biological Chemistry|December 22, 2007
Caveolin regulates endocytosis of the muscle repair protein, dysferlinDelia J Hernández-Deviez, Mark T Howes, Steven H Laval, et al.
Scientific Reports|January 28, 2016
Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular DystrophyJinhong Meng, John R Counsell, Mojgan Reza, et al.
Stem Cells and Development|July 9, 2013
Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutationsEmily Dick, Spandan Kalra, David Anderson, et al.
Human Molecular Genetics|December 2, 2005
Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3Delia J Hernández-Deviez, Sally Martin, Steven H Laval, et al.
Human Molecular Genetics|March 17, 2009
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophyYen-Hui Chiu, Mark A Hornsey, Lars Klinge, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neuromuscular Disorders : NMD|March 12, 2013
Muscular dystrophy in dysferlin-deficient mouse modelsMark A Hornsey, Steven H Laval, Rita Barresi, et al.
Human Molecular Genetics|February 12, 2010
Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromesJuliane S Müller, Catherine D Jepson, Steven H Laval, et al.
Nucleic Acid Therapeutics|July 16, 2015
Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino OligonucleotidesUmar Burki, Jonathan Keane, Alison Blain, et al.
Journal of Cardiovascular Translational Research|April 22, 2015
Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx MiceAlison Blain, Elizabeth Greally, Steven H Laval, et al.
Neuromuscular Disorders : NMD|December 3, 2014
Assessment of ventricular function in mouse models of muscular dystrophy: a comparison of MRI with conductance catheterAlison M Blain, Elizabeth Greally, Steven H Laval, et al.
The Journal of Biological Chemistry|December 22, 2007
Caveolin regulates endocytosis of the muscle repair protein, dysferlinDelia J Hernández-Deviez, Mark T Howes, Steven H Laval, et al.
Scientific Reports|January 28, 2016
Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular DystrophyJinhong Meng, John R Counsell, Mojgan Reza, et al.
Stem Cells and Development|July 9, 2013
Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutationsEmily Dick, Spandan Kalra, David Anderson, et al.
Human Molecular Genetics|December 2, 2005
Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3Delia J Hernández-Deviez, Sally Martin, Steven H Laval, et al.
Human Molecular Genetics|March 17, 2009
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophyYen-Hui Chiu, Mark A Hornsey, Lars Klinge, et al.
Pageof 2